Innoviva Q3 2025 revenue rises 20% to $107.8 million; net income $89.9 million
Innoviva reported third-quarter 2025 total revenue of $107.8 million, up 20% from a year earlier, and net income of $89.9 million, or $1.30 basic per share, compared with $1.2 million in the prior-year quarter. Income from operations fell 20% to $34.6 million, which the company attributed mainly to a non-recurring research and development expense, while net favorable changes in investment fair values drove the higher net income. The company also announced a new share repurchase program of up to $125 million.
Key points
- Total revenue was $107.8 million, up 20% from $89.5 million in Q3 2024.
- Net income was $89.9 million, or $1.30 basic per share, versus $1.2 million, or $0.02 per share, a year earlier.
- Income from operations was $34.6 million, down 20% from $43.2 million, mainly due to a non-recurring R&D expense.
- Board authorized a new share repurchase program of up to $125.0 million, with no termination date.
The filing
Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.